Formulation Development Outsourcing Market: Information By Services (Pre Formulation Services (Formulation Discovery, Pre-Clinical Services, Analytical Services), Formulation Optimization (Phase I, Phase II, Phase III, Phase IV), By Dosage Form (Injectable, Oral, Topical, Inhaled, Others), By Application (Oncology, Genetic Disorders, Neurology, Infectious Disease, Respiratory, Cardiovascular, Others), By End User (Pharmaceutical and Biopharmaceutical, Government and Academic Institutes) and Region (Americas, Europe, Asia-Pacific, and the Mi

Formulation Development Outsourcing Market Overview

Formulation Development Outsourcing Market is estimated to achieve a CAGR of 8.19% from 2020 to 2028 and can make up to 13.530 million USD by 2028. The Market is a major area of drug or product development that determines lifecycle, patentability, the success of a pharmaceutical product. Most pharmaceutical companies use it to minimize the time of outsourcing formulation service by investment involved in trials.

Formulation Development Outsourcing Market Growth is assigned by the increasing focus of biopharmaceutical companies that established academic partnerships. CRO or Contrast Research Organizations and biotechnology start-up companies started to develop formulations against disease.

COVID-19 Analysis

The threat of COVID-19 rapidly evolved various communities, businesses, lives, and industries around the world. WHO, World Health Organization organized and launched a clinical trial to find an effective treatment procedure in 2020. Though the COVID- 19 disrupted all he industries all over the world and numerous economies are working on their plan change to protect the employees and clients.

Formulation Development Outsourcing Market, by services, 2019 (%)

Source: MRFR Analysis

Market Dynamics

• Market Drivers

The growing importance of novel drugs and the implementation of the drugs increased the patent expiration of major drugs. It increases the outsourcing formulation of service by most of the biopharmaceutical companies which are the major market drivers of the Formulation Development Outsourcing Market. In the UK, cancer research promotes small drug discovery and funds various drug developing companies.

• Restraints

Increasing pricing of instruments, required for treatment and diagnosis, and testing is expected to restrain the Formulation Development Outsourcing Market Growth.  Along with that, structural changes in the pharmaceutical market also create issues in Formulation Development Outsourcing Industry Growth.

• Opportunities

The Formulation Development Outsourcing Market developed marketing to wits market substantial growth by reviewing the patent protection of medical drugs expiration. A rising number of biopharmaceutical and pharmaceutical companies outsource the services in the industry that created new opportunities in Formulation Development Outsourcing Market Size.

• Challenges

COVID-19 is the biggest challenge in Formulation Development Outsourcing Market. The increase of price and rage of various drugs, the raw materials can create huge issues in Formulation Development Outsourcing Market Value. 

• Cumulative Analysis

The Formulation Development Outsourcing Market Value is approx. 8.05 billion USD in 2020. The expected revenue of the industry is 12.650 billion USD in 2026, and 7.2% CAGR over the forecast period.  

Western Europe Formulation Development Outsourcing Market Share, by Country, 2019 (%)

Source: MRFR Analysis

Value Chain Analysis

Due to the increasing support of patents in dugs, the Formulation Development Outsourcing Market share will increase the value of the market. Various factors, such as supply chain development and the key player will promote and enhance the value chain in the market.

Market Segmentations

The Formulation Development Outsourcing Market Size is segmented into dosage form, services, end-user, and application. On the basis of services, the market is divided into Formulation Optimization and Reformulation Services. Furthermore, the Preformulation segment is again divided into Pre-Clinical Services, Analytical Services, and Formulation Discovery. The Formulation Optimization is again divided into Phase III, Phase II, and Phase I.

On the basis of dosage form, the Formulation Development Outsourcing Market is again segmented into Inhaled, Topical, Injected, Oral, and Others. In the year 2019, the injectable segment held the largest growth.

On the basis of application, the market is again segmented into neurology, cardiovascular, Oncology, Infectious Diseases, Genetic Disorders, Respiratory, and Others.  The oncology sub-segment is anticipated to grow at the fastest rate in the studied forecast period.

On the basis of end-user, the market is again divided into Academic and Government Institutes and Biopharmaceuticals, and Pharmaceutical Companies. However, biopharmaceutical and pharmaceutical companies are expected to grow at the fastest rate. 

Regional Analysis

Regionally, the Formulation Development Outsourcing Market Size is divided into Europe, Americas, Asia-Pacific, Africa, and the Middle East. However, the Americas segment is divided into Latin America and North America. Previously, in 2019, the Americas held the largest share in 2019. Therefore, the increasing cases of chronic diseases and the development of drugs will drive the market in this region.

Along with that, Europe is anticipated to hold the second-largest Formulation Development Outsourcing Market Share. The supportive initiatives by the government, sedentary lifestyle and increasing chronic diseases are driving the market in this region.

Thirdly, the Asia-Pacific region is anticipated to record the fastest CAGR in the forecast period. This region consists of counties such as India, South Korea, China, Australia, etc. Hence, the increasing demand for drug development and the presence of pharmaceutical companies will boost the market in this region. However, Africa and the Middle East region are anticipated to record gradual growth in the upcoming years.

Competitive Landscape

 The Formulation Development Outsourcing Market is fragmented with the presence of various key players. Some of the key players in the market are as follows.

• Charles Rover laboratories (US)


• Laboratory Corporation of America (US)


• Intertek (US)


• Quotient Sciences


• Reddy’s Laboratories (India)


• Catalent Inc. (US)


• Thermo Fischer Scientific Inc. (US)


• Emergent Biosolutions Inc.(US)


• Aizant Drug Research Solutions Pvt. Ltd.(US)


• Lonza Group AG(Switzerland)


• Syngene International Limited (India)


• Irisys LLC Laboratory Corporation of America Holdings (US)

Recent Developments

• Catalent Inc. in 2020 announced the acquisition of a company called MaStherCell Global Inc. This expansion will lead to expanding the position of the biotech industry and provide new techniques for gene therapy.


• Intertek in 2019 expanded its pharmaceutical services laboratory situated in Melbourne.


• Cataleny Inc. in 2021 announced the acquisition of the packaging and manufacturing operations of a company called Acorda Therapeutics Inc.


• Quotient BioSciences in 2021 also announced the acquisition of a company based in the UK called Arcinova. This acquisition will expand the business portfolio of Quotient Bioscience such as drug products, clinical testing, as well as drug substance improvement.

Report Overview

The report overview of the Formulation Development Outsourcing Market Outlook is as followed.

• Market Overview


• COVID-19 analysis


• Market Dynamics


• Value Chain Analysis


• Market Segmentations


• Regional Analysis


• Competitive Landscape


• Recent Developments

Report Score and Segmentation

The report score provides valuable information about the Formulation Development Outsourcing Market Forecast. It covers information such as CAGR, recent developments by key players, drivers, challenges, etc. However, the information provided in this report is collected from various secondary and primary sources.

• Study Period- 2021-2028


• Base Year- 2021


• Forecast Period- 2021-2028


• Historical Period- 2015-2020

Segmentation

• Formulation Optimization


• Phase II


• Phase IV


• Phase I


• Phase III


• Pre-Formulation Services


• Preclinical Services


• Formulation Services


• Analytical Service

• Topical


• Oral


• Injectable


• Inhaled


• Others

• Neurology


• Respiratory


• Cardiovascular


• Oncology


• Infectious Diseases


• Genetic Disorders


• Other

• Academic ad Government Institutes


• Biopharmaceutical and Pharmaceutical Companie

• Europe


• Americas


• Asia-Pacific


• Africa and the Middle East